Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Insights into mitochondrial complex I disorders using the ATPlite luminescence assay
atp lite mitochondrial
Literature - Publication Review

Insights into mitochondrial complex I disorders using the ATPlite luminescence assay

This literature review shows how researchers have taken advantage of ATPlite luminescence assay to assess mitochondrial health, detect metabolic shifts and evaluate potential treatment strategies.

The review features:

  • An introduction to the mechanism of Mitochondrial complex I
  • Various case studies about complex I research
  • Data from published scientific literature

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

* が付いているフィールドは入力必須です
お客様は個人データを送信することにより、Revvity Inc. およびその関連会社(以下「当社」)が、当社のプライバシーポリシー(ご覧になるにはこちらをクリック)に従って上記で提供されたお客様の個人データを処理することに同意するものとします。

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

Insights into mitochondrial complex I disorders using the ATPlite luminescence assay

Download Literature - Publication Review
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.